Analyst Profile

Followed by 375 followers
.
Ricky Goldwasser

Ricky Goldwasser

Morgan Stanley
Wall Street Analyst
#221 out of 8,141 Wall Street Analysts
#391 out of 24,284 experts

Success Rate

65%
209 out of 321 transactions made a profit

Average Return

+13.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Ricky Goldwasser's trades since 2014 and holding each position for 1 Year would result in 65.11% of your transactions generating a profit, with an average return of 13.3% per rating.

Stock Rating Distribution

496Ratings
62.10% Buy
28.43% Hold
9.48% Sell
Distribution of Ricky Goldwasser's ratings

Additional Information

Main Sector:Services
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Livongo Health
(LVGO)
Rating:Buy
Date:Mar 27, 2020 - Mar 27, 2021
Return:+476.80%
The most profitable rating made by Ricky Goldwasser

Ricky Goldwasser's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
CVD
Covance Inc
Feb 05, 2014
Hold
Reiterated
1Ratings
0.00%
CTRX
Catamaran
Oct 09, 2014
Hold
Reiterated
4Ratings
0.00%
Alphabet Class A
Apr 24, 2015
Hold
Reiterated
$565.00
(479.73% Upside)
1Ratings
0.00%
AMRI
Albany Molecular Research
Aug 05, 2016
Buy
Reiterated
8Ratings
80%
+11.30%
PTHN
Patheon NV
Aug 15, 2016
Buy
Reiterated
1Ratings
100%
+26.90%
ESRX
Express Scripts
Sep 08, 2016
Sell
Reiterated
13Ratings
83%
+10.87%
CSLT
Castlight Health
Jan 30, 2018
Sell
Reiterated
1Ratings
100%
+18.20%
~ATHN
Athenahealth
Dec 03, 2018
Hold
Reiterated
15Ratings
14%
-13.17%
DPLO
Diplomat Pharmacy
Nov 13, 2019
Hold
Reiterated
8Ratings
0%
-31.90%
LVGO
Livongo Health
Jul 07, 2020
Buy
Reiterated
6Ratings
100%
+284.04%
List of latest recommendations made by Ricky Goldwasser. Click to expand and see Ricky Goldwasser's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >